Clinical Trials Browser

Phase 1 × Hematologic Neoplasms × Paclitaxel × Clear all

NCT05828459 2025-03-20

First-in-human Study of OT-A201 in Patients With Selected Hematological Malignancies and Solid Tumors

Phase 1 Recruiting

Other hematologic neoplasm

Hematologic Neoplasms

NCT01351350 2019-08-08

Dose Escalation Study of MLN0128 in Combination With Paclitaxel, With/Without Trastuzumab, in Subjects With Advanced Solid Malignancies

Phase 1 Completed

68 enrolled 29 charts

Other hematologic neoplasm

Hematologic Neoplasms